Eli Lilly and Co. plans to invest more than $1 billion in India to expand manufacturing and supply through local drugmakers, as reported by Reuters.  Lilly aims to increase availability of key drugs for obesity, diabetes, Alzheimer’s, cancer and autoimmune conditions, according to the company. The company launched its weight-loss drug Mounjaro in India this year and does not currently operate its own manufacturing facility in the country. “We are making significant investments ...